Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Animi-3 with Vitamin D is a **combination prescription nutraceutical product** formulated to improve nutritional status in patients requiring supplementation of **essential fatty acids, B vitamins (B6, B9, B12), vitamin D3, and plant sterols**. Each capsule typically contains folic acid (1 mg), cholecalciferol (vitamin D3, 1000 IU), pyridoxine hydrochloride (vitamin B6, 12.5 mg), cyanocobalamin (vitamin B12, 500 mcg), omega-3 fatty acids (500 mg, including 350 mg DHA and 35 mg EPA), and phytosterols (200 mg). The mechanism of action reflects the physiological roles of these nutrients: support of lipid metabolism, reduction of triglycerides, improvement of cardiovascular and neurological health, and correction of nutritional deficiencies. It is prescribed for conditions requiring targeted nutritional supplementation[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on animi-3 + vitamin d.